How has been the historical performance of Krsnaa Diagnost.?

Revenue and Profit Growth

Over the four-year period, Krsnaa Diagnost. has seen its net sales increase steadily from ₹455.45 crores in March 2022 to ₹717.16 crores in March 2025. This represents a compound growth trend reflecting the company’s expanding market presence and operational scale. Total operating income mirrored this growth, with no other operating income reported, indicating that core business activities have been the primary revenue drivers.

Operating profit before depreciation and interest (PBDIT excluding other income) rose from ₹131.48 crores in March 2022 to ₹190.12 crores in March 2025, signalling improved operational efficiency. Including other income, operating profit (PBDIT) increased from ₹146.39 crores to ₹215.66 crores over the same period. However, profit before tax showed some volatility, peaking at ₹102.69 crores in March 2025 after a dip in the previous years.

Profit after tax (PAT) followed a similar pattern, declining from ₹68.39 crores in March 2022 to ₹56.84 crores in March 2024 before rebounding to ₹77.61 crores in March 2025. Earnings per share (EPS) also reflected this recovery, rising to ₹24.03 in March 2025 from ₹17.60 the year prior.

Cost Structure and Margins

The company’s expenditure profile reveals rising raw material costs, which increased from ₹60.30 crores in March 2022 to ₹169.26 crores in March 2025, consistent with the revenue growth. Employee costs also rose significantly, reflecting workforce expansion and possibly wage inflation, reaching ₹136.78 crores in the latest fiscal year.

Selling and distribution expenses have decreased over the years, from ₹107.99 crores in March 2022 to ₹60.68 crores in March 2025, indicating improved cost control or changes in marketing strategy. Other expenses have also increased steadily, which may relate to operational scaling.

Operating profit margins excluding other income have fluctuated, declining from 28.87% in March 2022 to 26.51% in March 2025, with a low point in the intervening years. PAT margins have similarly contracted from 15.02% to 10.82% over the same period, suggesting pressure on net profitability despite top-line growth.

Balance Sheet and Financial Position

Krsnaa Diagnost.’s balance sheet shows a strengthening equity base, with shareholder’s funds rising from ₹684.41 crores in March 2022 to ₹882.77 crores in March 2025. Reserves have also grown, supporting the company’s retained earnings and financial stability. The book value per share has appreciated from ₹217.98 to ₹273.39, reflecting value accretion for shareholders.

Total liabilities have increased from ₹875.37 crores to ₹1,278.26 crores, driven largely by a rise in current liabilities and short-term borrowings, which surged notably in the latest fiscal year. Long-term borrowings have fluctuated but remain relatively modest. The company’s gross block of fixed assets has expanded significantly, indicating ongoing capital investment and capacity enhancement.

Cash Flow Trends

Operating cash flow has been positive but variable, with ₹87 crores generated in March 2025 compared to ₹128 crores in March 2022. Investing activities have consistently consumed cash, reflecting capital expenditure commitments. Financing activities have varied, with a positive inflow in the latest year after a mixed pattern in prior years. The net cash position remains modest, with closing cash and equivalents at ₹3 crores in March 2025, down from ₹88 crores three years earlier.

Summary and Investor Considerations

In summary, Krsnaa Diagnost. has exhibited robust revenue growth and expanding operating profits over the past four years, supported by strategic investments and an increasing asset base. However, the company has faced margin pressures and fluctuating net profits, alongside rising borrowings and a tightening cash position. Investors should weigh the company’s growth potential against these financial dynamics and consider sector trends and competitive positioning when evaluating its prospects.

Overall, the historical performance suggests a company in expansion mode, balancing growth with operational challenges typical of its industry segment.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →